Malaria News and Research

Latest Malaria News and Research

Study shows artemisinin-resistant malaria parasite spreading along Thai-Myanmar border

A strain of malaria that is resistant to artemisinin combination therapy (ACT) is spreading along the Thai-Myanmar border and has the potential to spread to Africa if efforts to effectively treat and prevent the disease are not undertaken, according to a study published in the Lancet on Friday, Reuters reports.

7 Apr 2012

PloS ONE publishes research on GenVec's new vaccine vectors

GenVec, Inc. announced publication of research on GenVec's new vaccine vectors. These vectors circumvent neutralizing antibodies in order to generate the desired immunologic response.

7 Apr 2012

NIH to award $20M over 5 years to support global health training for scientists

"A network of global health research training institutions will increasingly focus on the rising levels of chronic diseases in developing countries, the National Institutes of Health Fogarty International Center announced on Wednesday," CQ HealthBeat reports (Bristol, 4/4).

6 Apr 2012

Global Fund updates global health community advocates on recent changes to organization

"Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on ... the multilateral organization," the Center for Global Health Policy's "Science Speaks" blog reports.

6 Apr 2012

Scientists identify how Clec9A protein recognises foreign invaders

The discovery of how a vital immune cell recognises dead and damaged body cells could modernise vaccine technology by 'tricking' cells into launching an immune response, leading to next-generation vaccines that are more specific, more effective and have fewer side-effects.

6 Apr 2012

Drug resistance woes hamper anti-malaria fight

Researchers have found that there is increasing resistance to the front-line treatments for malaria. A pair of studies published in The Lancet and the journal Science showed how the disease is moving fast into new territory and identified a region of the parasite's genome that may be responsible for mutating in order to survive.

5 Apr 2012

Fogarty receives NIH grant to help foster next generation of global health scientists

To help foster the next generation of global health scientists, Fogarty International Center and its partners at the National Institutes of Health are building a network of U.S. academic institutions to provide early-career physicians, veterinarians, dentists and scientists with a significant mentored research experience in a developing country.

5 Apr 2012

Walter and Eliza Hall Institute researchers receive five ASBMB awards

Walter and Eliza Hall Institute researchers have received five of the 11 awards for excellence in biochemistry and microbiology announced by the Australian Society of Biochemistry and Molecular Biology (ASBMB) this month.

5 Apr 2012

Combination treatment effective against melanoma

Research from The Cancer Institute of New Jersey (CINJ) shows that a coordinated effort to block signaling pathways that promote cancer cell growth and survival enhances programmed cell death in melanoma.

3 Apr 2012

Computer model can predict malaria epidemics in India

Scientists from the University of Liverpool are working with computer modelling specialists in India to predict areas of the country that are at most risk of malaria outbreaks, following changes in monsoon rainfall.

3 Apr 2012

IPT has an ongoing protective effect against malaria in infants

Malaria infections among infants can be cut by up to 30 per cent when antimalarial drugs are given intermittently over a 12 month period, a three-year clinical trial in Papua New Guinea has shown.

2 Apr 2012

Inovio awarded U.S. DOD grant to advance non-invasive surface electroporation delivery device

Inovio Pharmaceuticals, Inc. announced today it has received a U.S. Department of Defense Small Business Innovation Research Grant to advance the development of a low-cost, non-invasive surface electroporation (EP) delivery device and test its utility in combination with Inovio's novel synthetic DNA vaccines against viruses with bioterrorism potential, including hanta, puumala, arenavirus and pandemic influenza.

2 Apr 2012

Study examines TB services in prisons in countries receiving Global Fund grants

According to a study recently published in a special supplement of the Journal of Infectious Diseases, half of countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria provide tuberculosis (TB) services in prisons; "even when TB services were provided to prisoners, they were limited in scope; and "few of the programs receiving a grant from the Global Fund offered services dedicated to the treatment and prevention of multi-drug resistant TB (MDR-TB)," an aidsmap news story reports.

31 Mar 2012

'Large-scale action' needed in Myanmar to prevent spread of artemisinin-resistant malaria parasites

In this New York Times opinion piece, Frank Smithuis, director of Medical Action Myanmar in Yangon, and Nick White, professor of tropical medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, recount a brief history of the development of anti-malaria drugs and their contribution to "a significant global reduction in malaria" and note that this progress "is now threatened by the emergence of malaria parasites that are resistant to artemisinin on the Cambodia-Thailand border ..., the same place where chloroquine resistance emerged 50 years ago and spread across Asia and Africa to claim millions of lives."

31 Mar 2012

Dengue infection makes mosquito's blood feeding more efficient

Mosquitoes infected with dengue virus experience an array of changes in the activity of genes and associated functions of their salivary glands, and these changes may lead to increased virus transmission, according to a recent study led by George Dimopoulos, Ph.D., of the Malaria Research Institute and Bloomberg School of Public Health at Johns Hopkins University.

31 Mar 2012

Data from Cempra's CEM-101 Phase 2 trial on N. gonorrhoeae infections to be presented at ECCMID

Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrating that CEM-101 (solithromycin) is active against antibiotic-resistant strains of N. gonorrhoeae.

31 Mar 2012

Data from Cempra's CEM-101 Phase 2 trial on CABP to be presented at ECCMID

Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.

31 Mar 2012

Infection with dengue virus turns on feeding-related genes in mosquitoes

Researchers at the Johns Hopkins Bloomberg School of Public Health have, for the first time, shown that infection with dengue virus turns on mosquito genes that makes them hungrier and better feeders, and therefore possibly more likely to spread the disease to humans.

30 Mar 2012

Global Fund's general manager discusses future direction, achievement of fund in interview

Gabriel Jaramillo, general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, "has given an interview with the Spanish newspaper El Mundo, in which he outlines the direction and achievements to-date in making the Global Fund a more efficient and successful organization," according to a Global Fund press release.

29 Mar 2012

P. falciparum colonizes America via two separate introduction routes: Study

The malaria parasite, Plasmodium falciparum, originates from Africa, and is found on every continent. Over 200 million people are infected every year from Africa to Asia, as well as in America and the Middle East. How did it spread to the entire planet? It is not entirely clear how it conquered the New World. Scientists from the UMR Migevec and their partners have recently shown in the journal PNAS that the pathogen was introduced by ship during the slave trade.

29 Mar 2012

Malaria News and Research

Latest Malaria News and Research

Study shows artemisinin-resistant malaria parasite spreading along Thai-Myanmar border

PloS ONE publishes research on GenVec's new vaccine vectors

NIH to award $20M over 5 years to support global health training for scientists

Global Fund updates global health community advocates on recent changes to organization

Scientists identify how Clec9A protein recognises foreign invaders

Drug resistance woes hamper anti-malaria fight

Fogarty receives NIH grant to help foster next generation of global health scientists

Walter and Eliza Hall Institute researchers receive five ASBMB awards

Combination treatment effective against melanoma

Computer model can predict malaria epidemics in India

IPT has an ongoing protective effect against malaria in infants

Inovio awarded U.S. DOD grant to advance non-invasive surface electroporation delivery device

Study examines TB services in prisons in countries receiving Global Fund grants

'Large-scale action' needed in Myanmar to prevent spread of artemisinin-resistant malaria parasites

Dengue infection makes mosquito's blood feeding more efficient

Data from Cempra's CEM-101 Phase 2 trial on N. gonorrhoeae infections to be presented at ECCMID

Data from Cempra's CEM-101 Phase 2 trial on CABP to be presented at ECCMID

Infection with dengue virus turns on feeding-related genes in mosquitoes

Global Fund's general manager discusses future direction, achievement of fund in interview

P. falciparum colonizes America via two separate introduction routes: Study

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Malaria News and Research

Latest Malaria News and Research

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in